E.coli-derived human EBAG9 recombinant protein (Position: R31-S213). Human EBAG9 shares 97.8% and 94.5% amino acid (aa) sequence identity with mouse and rat EBAG9, respectively.
Each vial contains 50% glycerol, 0.9% NaCl, 0.2% Na2HPO4.
Reinheit:
Immunogen affinity purified.
Formulierung:
Liquid
Target-Kategorie:
Receptor-binding cancer antigen expressed on SiSo cells
Application Verdünnung:
Western blot, Optimal dilutions should be determined by end users. Immunohistochemistry (Paraffin-embedded Section), Optimal dilutions should be determined by end users. ELISA, Optimal dilutions should be determined by end users.
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
